hotspot
Previous article:
Affirmative action in medical school literally saved lives
Next article: With trial win, GSK could get blood cancer drug back on market
Next article: With trial win, GSK could get blood cancer drug back on market
explore
focus
-
Readout LOUD podcast: ASCO preview, a Duchenne trial failure
2025-09-29 23:23 -
ASCO: AstraZeneca's hat trick, and palliative care's spotlight
2025-09-29 22:50 -
Ionis has late
2025-09-29 22:43 -
Listen: Who gets the credit for GLP
2025-09-29 22:02 -
At ASCO, pharma leaders speak of advances in 'smart bomb' drugs
2025-09-29 21:46 -
Address the ethical violations that led to 'Three Identical Strangers'
2025-09-29 21:37